Loading
Everything OnCo dates to 1958: 8 entries, 4 landmarks, 2 technologies, 1 approval and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
8 dated entries in OnCo fall in 1958: 4 landmarks, 2 technologies, 1 approval and 1 company founded.
Of those, 8 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Palliative management of leukaemias and lymphomas; inflammatory and allergic conditions
The history entries editors wrote on cancer records: the dated turning points of each disease.
Hairy cell leukaemia
Burkitt lymphoma. Later maps its distribution to the malaria belt.
Multiple myeloma
HR-positive / HER2-negative breast cancer. Basis for predicting hormone responsiveness.
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
The founded year on company records.
Pittsburgh, PA